Elise Ramia

CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens.

Brian J. Stevenson, G. Forlani, M. Linnebacher, 2020, Molecular & cellular proteomics : MCP.

CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine

G. Forlani, A. Tedeschi, R. Accolla, 2019, Front. Immunol..

Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1

G. Forlani, A. Tedeschi, R. Accolla, 2019, Retrovirology.

Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells

G. Forlani, R. Accolla, G. Tosi, 2017, Oncoimmunology.

CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches

G. Forlani, A. Tedeschi, F. Sessa, 2018, Oncoimmunology.

Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells

G. Forlani, R. Accolla, G. Tosi, 2017, Oncoimmunology.